Healthcare - Page 1 | TalkMarkets
All Posts > Content under Healthcare
1 to 16 of 5561 Posts
1 2 3 ... 348
Bull Of The Day: Amgen (AMGN)
Article By: Zacks Investment Research
Friday, September 20, 2019 9:52 AM EDT
Amgen is so far past that stage that they look attractive on a valuation basis just based on current lines of business. The potential for new best-selling drugs is just gravy for shareholders.
In this article: AMGN
POTX: A Potent Pot ETF Debuts
Article By: Benzinga
Friday, September 20, 2019 9:19 AM EDT
Integral to POTX's long-term fortunes and those of its passive rivals will be the ability of Canadian cannabis firms to gain footholds in the fast-growing, likely more lucrative U.S. market.
In this article: POTX Also: CGC, CRON, MJ, ACB
Tilray Inc. Bull Flag Ready To Blast
Article By: Gareth Soloway
Thursday, September 19, 2019 2:01 PM EDT
Share of Tilray Inc (TLRY) are putting in a gorgeous bull flag consolidation pattern. This signals major upside in the coming days.
In this article: TLRY
Corning (GLW) Sunk After Cutting Its Outlook And Still Has Lower To Go
Article By: Nick Santiago
Thursday, September 19, 2019 1:08 PM EDT
Leading specialty glass and ceramics manufacturer, Corning Inc., tumbled after cutting its outlook for two large parts of its business.
In this article: GLW
Bull Of The Day - GW Pharmaceuticals
Article By: Kevin Cook
Thursday, September 19, 2019 10:02 AM EDT
GW Pharma delivered a bigger sales beat for Epidiolex than even the most optimistic analysts were projecting. GWPH crushed the sales number for the treatment of two rare forms of pediatric epilepsy with $68 million vs. consensus of $45M.
In this article: GWPH
E Cannabis Central: Major Resurgence In Larger Cap Pot Stocks To Date In September
Article By: Lorimer Wilson
Sunday, September 15, 2019 7:00 PM EDT
So far in September, the 19 pure play non-penny marijuana stocks are up 10.5% compared to just a 2.3% return for the 313 pot stock universe strongly suggesting that the resurgence came almost exclusively from the larger cap stocks in this sector.
In this article: CGC, MJ, TLRY, ACRGF, YOLO, VFF, THCX, CNBS
Medtronic Strong Quality And Reasonable Valuation
Article By: Andres Cardenal
Saturday, September 14, 2019 12:00 PM EDT
Medtronic is a high-quality business with solid competitive strength. Management is reducing expenses and accelerating revenue growth in emerging markets.
In this article: MDT
E Cannabis Central: Aurora Cannabis Q4 Results Show 52% Increase In Revenue, 68% Improvement In EBITDA
Article By: Lorimer Wilson
Friday, September 13, 2019 4:10 AM EDT
Aurora Cannabis Inc. yesterday announced its financial and operational results for the fourth quarter and fiscal year ended June 30, 2019.
In this article: ACB
E A Ranking Of Marijuana ETF Performances In August - Who Was #1?
Article By: Lorimer Wilson
Wednesday, September 11, 2019 6:31 PM EDT
Not all cannabis ETFs perform equally well given their constituents and below is the performance of each in August ranked from best (-3.5%) to worst (-16.0%).
In this article: ACT, APHA Also: CGC, NEPT, CRON, MJ, YOLO, OGI, THCX, CNBS
Aurora Trades Down On Q4 Print, Company Preparing 'Robust Product Lineup' For December Launch In Canada
Article By: Benzinga
Wednesday, September 11, 2019 5:49 PM EDT
Aurora Cannabis Inc ACB narrowly missed its own fourth-quarter net revenue estimate, posting a figure of CA$98.9 million ($74.9 million) after previously guiding to a range of CA$100-$107 million.
In this article: ACB
Tilray To Sell Up To $400M In Shares Via Cowen
Article By: Benzinga
Wednesday, September 11, 2019 10:31 AM EDT
Cannabis company Tilray Inc. announced Tuesday via an 8-K filing that it has signed a sales agreement with Cowen and Company, LLC, upon which the company can issue and sell shares via Cowen with a total offering price of up to $400 million.
In this article: TLRY Also: COWN
Indicator Of The Day: S&P Health Care Stocks Above 20 EMA
Video By: T.J. Hayes
Tuesday, September 10, 2019 11:12 AM EDT
Our Stock Market Indicator of the Day is: S&P 500 Health Care Stocks Above 20 EMA
In this video: XLV
E Matinas Biopharma Is Highly Undervalued
Article By: Terry Chrisomalis
Monday, September 9, 2019 7:13 AM EDT
With cash concerns put to rest, a solid lead product MAT9001, and a unique lipid nano-crystal delivery technology, I believe Matinas Biopharma is highly undervalued.
In this article: MTNB Also: LGND, XOMA, AMRN, ABUS
E Cannabis Central: How Best To Invest In The Marijuana Market
Article By: Lorimer Wilson
Sunday, September 8, 2019 10:39 PM EDT
The August performance of 9 categories within the cannabis sector varied considerably ranging from + 40% to -18.5%. That is a dramatic spread and one worth understanding should you wish to position yourself in this burgeoning market sector.
E Best Long-Term Performance Health Sector ETFs
Article By: Micah H. McDonald
Sunday, September 8, 2019 8:17 PM EDT
Health Sector ETFs have a good long-term track record. There are 38 ETFs available in the Health category, 16 of these have been available for 10 years or longer. This article focuses on the long-term performance of these 16 older Health Sector ETFs.
In this article: FBT, IHI, XBI, XLV
E 5 CBD Stock Picks - No Weeds In This Garden
Article By: David Moadel
Thursday, September 5, 2019 10:46 PM EDT
The CBD market is growing by leaps and bounds; here's a prime sampling of cannabidiol stocks to round out your canna-centric holdings.
In this article: CGC, GGBXF, CRON, ACB, CWBHF
1 to 16 of 5561 Posts
1 2 3 ... 348